Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “New York”
Sponsor: Boehringer Ingelheim
Focal Segmental Glomerulosclerosis
United States, Argentina, Australia, Belgium, Brazil +35 more
Sponsor: VA Office of Research and Development
Chronic Kidney Disease (CKD) Stage 5 · Kidney Dysfunction Requiring Dialysis (KDRD) · Dialysis Dependency
United States
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruiting
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
United States, Australia, Brazil, Canada, China +8 more
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemia, Myelodysplasia-Related
United States, Canada, Puerto Rico
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Belgium, Denmark, France, Israel +3 more
- A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD TherapyActive Not Recruiting
Sponsor: University of Maryland, Baltimore
Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis
United States
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Positive Breast Carcinoma
United States, Puerto Rico
Sponsor: Janssen Research & Development, LLC
Metastatic Castration-sensitive Prostate Cancer
United States, Argentina, Australia, Belarus, Belgium +28 more
Sponsor: CSL Behring
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
United States, Australia, Austria, Belgium, Canada +13 more
- A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DMEActive Not Recruiting
Sponsor: EyeBiotech Ltd.
Diabetic Macular Edema (DME)
United States, Argentina, Brazil, Colombia, Japan +1 more
Sponsor: BeOne Medicines
HR+/HER2- Breast Cancer
United States, Australia, Brazil, China, Japan +5 more
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaActive Not Recruiting
Sponsor: Children's Oncology Group
Acute Lymphoblastic Leukemia · B Acute Lymphoblastic Leukemia · Mixed Phenotype Acute Leukemia · T Acute Lymphoblastic Leukemia
United States, Australia, Austria, Belgium, Canada +14 more
Sponsor: Alnylam Pharmaceuticals
High Risk Cardiovascular Disease · Hypertension · High Cardiovascular Risk
United States, Argentina, Australia, Austria, Belgium +29 more
- Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPCActive Not Recruiting
Sponsor: Weill Medical College of Cornell University
Prostate Cancer
United States
Sponsor: National Cancer Institute (NCI)
Ganglioneuroblastoma, Nodular · Neuroblastoma
United States, Australia, Canada, New Zealand, Puerto Rico
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruiting
Sponsor: National Cancer Institute (NCI)
Low Grade Astrocytoma · Low Grade Glioma · Metastatic Low Grade Astrocytoma · Metastatic Low Grade Glioma
United States, Canada, Puerto Rico
- A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone LymphomaActive Not Recruiting
Sponsor: BeOne Medicines
Relapsed/Refractory Follicular Lymphoma · Marginal Zone Lymphoma
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Regeneron Pharmaceuticals
Melanoma
United States, Canada
- Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryActive Not Recruiting
Sponsor: ECOG-ACRIN Cancer Research Group
Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 · Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
United States
- Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeActive Not Recruiting
Sponsor: Children's Oncology Group
Acute Myeloid Leukemia · Down Syndrome · Myelodysplastic Syndrome · Myeloid Leukemia Associated With Down Syndrome
United States, Australia, Canada, New Zealand, Puerto Rico +1 more
- Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin LymphomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Recurrent Classic Hodgkin Lymphoma · Refractory Classic Hodgkin Lymphoma
United States
Sponsor: Wayne State University
Dilated Cardiomyopathy · Hypertrophic Cardiomyopathy
United States, Canada
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8
United States, Guam
- A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFActive Not Recruiting
Sponsor: ReCode Therapeutics
Cystic Fibrosis
United States, France, Netherlands, New Zealand, United Kingdom
- Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Breast Adenocarcinoma
United States, Peru, South Africa